beta
Trial Radar AI
Clinical Trial NCT07438080 (ALONDEPISTHPV) for HPV is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study (ALONDEPISTHPV) 300 Randomized Crossover Design

Recruiting
Clinical Trial NCT07438080 (ALONDEPISTHPV) is an interventional study for HPV that is recruiting. It started on April 9, 2025 with plans to enroll 300 participants. Led by Centre Hospitalier Universitaire de la Réunion, it is expected to complete by March 1, 2028. The latest data from ClinicalTrials.gov was last updated on February 27, 2026.
Brief Summary
Comunity health actions are set up in populations of women aged 30 to 65 in vulnerable situations living in the outlying areas of Reunion Island.

The idea is to evaluate those action on health

Official Title

Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study

Conditions
HPV
Other Study IDs
  • ALONDEPISTHPV
  • 2023/CHU/37
  • 2023-A02588-37 (Registry Identifier) (IDRCB)
NCT ID Number
NCT07438080
Start Date (Actual)
2025-04-09
Last Update Posted
2026-02-27
Completion Date (Estimated)
2028-03-01
Enrollment (Estimated)
300
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Primary Purpose
Prevention
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Experimentalparticipant
1. Awareness workshops on uterine cancer screening - small group workshops conducted in the form of discussion groups 2. Proposal for an HPV self-test (vaginal self-swab to detect high-risk HPV) as part of an individual consultation for participants whose CC screening is not up to date
Public health workshop in community
1\) Cervical cancer screening awareness workshops, conducted in small groups through focus groups. -2) Proposal for an HPV self-test (vaginal self-swab to detect high-risk HPV) as part of an individual consultation for participants who are not up-to-date with their cervical cancer screening.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Rate of women who complete cervical cancer screening after the community health intervention,
Rate of women aged 30 to 65 years living in vulnerable areas of Reunion Island who complete cervical cancer screening (HPV test or Pap smear) within 3months after the community health intervention, as documented in medical records or screening databases.
3 months
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
30 Years
Eligible Sexes
Female
  • Aged 30 to 65,
  • In a vulnerable situation (beneficiary of a state or departmental social service, or referred by a charity),
  • Resident in one of the two municipalities targeted by the study,
  • Supported by the social services of one of the two municipalities targeted by the study,
  • Having agreed to participate in sexual health awareness meetings organized on site

  • Refusing to participate in the study
  • Having had a hysterectomy
Centre Hospitalier Universitaire de la Réunion logoCentre Hospitalier Universitaire de la Réunion
Study Central Contact
Contact: Emmanuelle THORE, dr, +262 262 74 23 80, [email protected]
2 Study Locations in 1 Countries
Cegidd Saint Paul, Saint-Paul, France
Emmanuelle THORE, Dr, Contact, 0262 45 30 30, [email protected]
Dr Emmanuelle THORE, Principal Investigator
Recruiting
CegiDD Saint Pierre, Saint-Pierre, France
Dr Phuong TRAN, Contact, 0262 35 96 10, [email protected]
Recruiting